/index.html View the latest 精东影业. news releases. /news/2024/news202477.html Eisai's news release A Joint Regional Cohort Study by Shimadzu, Eisai, Oita University, and Usuki City Medical Association Demonstrating the Utility of Blood Biomarkers in Predicting Amyloid Beta Accumulation in the Brain is posted. 2024-10-17T10:00:00+09:00 /news/2024/news202476.html Eisai's news release UPDATE ON REGULATORY REVIEW OF LECANEMAB FOR EARLY ALZHEIMER鈥橲 DISEASE IN AUSTRALIA is posted. 2024-10-17T08:30:00+09:00 /news/2024/news202475.html Eisai's news release AMYOTROPHIC LATERAL SCLEROSIS TREATMENT 鈥淩OZEBALAMIN庐 FOR INJECTION 25 MG鈥� RECEIVES THE GOOD DESIGN AWARD 2024 FOR LIGHT-PROOF VIAL PACKAGING is posted. 2024-10-16T14:00:00+09:00 /news/2024/news202474.html Eisai's news release 鈥淯RECE庐 TABLETS鈥� (DOTINURAD) APPROVED IN THAILAND FOR GOUT AND HYPERURICEMIA is posted. 2024-10-08T08:30:00+09:00 /news/2024/news202473.html Eisai's news release 精东影业Announces Status and Completion of Acquisition of Own Shares is posted. 2024-10-04T15:35:00+09:00 /news/2024/news202472.html Eisai's news release EISAI COMMENCES BUSINESS ACTIVITIES AT NEW PHARMA SALES SUBSIDIARY IN SAUDI ARABIA is posted. 2024-10-02T08:30:00+09:00 /news/2024/news202471.html Eisai's news release 精东影业Announces Status Relating to Acquisition of Own Shares is posted. 2024-10-01T11:30:00+09:00 /news/2024/news202469.html Eisai's news release ROZEBALAMIN庐 FOR INJECTION 25 MG (MECOBALAMIN) APPROVED IN JAPAN FOR AMYOTROPHIC LATERAL SCLEROSIS is posted. 2024-09-24T14:45:00+09:00 /news/2024/news202468.html Eisai's news release ANTICANCER AGENT 鈥淭ASFYGO庐 TABLETS 35mg鈥� (TASURGRATINIB SUCCINATE) APPROVED IN JAPAN FOR BILIARY TRACT CANCER WITH FGFR2 GENE FUSIONS OR REARRANGEMENTS is posted. 2024-09-24T14:30:00+09:00 /news/2024/news202467.html Eisai's news release RELEASE OF DEMENTIA DISEASE AWARENESS VIDEO FOR WORLD ALZHEIMER鈥橲 MONTH 鈥淭ODAY FOR TOMORROW鈥�: A DOCUMENTARY OF SIX MONTHS FOLLOWING THE CURRENT STATE OF DEMENTIA is posted. 2024-09-17T10:00:00+09:00 /news/2024/news202466.html Eisai's news release LENVIMA庐 (lenvatinib) Plus KEYTRUDA庐 (pembrolizumab) in Combination With Transarterial Chemoembolization (TACE) Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma is posted. 2024-09-17T08:30:00+09:00 /news/2024/news202465.html Eisai's news release Investigator-initiated clinical studies to be launched following confirmation of tumor shrinkage induced by the targeted protein degrader E7820 using J-PDX (Japanese cancer patient-derived tissue transplantation models) is posted. 2024-09-12T16:07:24+09:00 /news/2024/news202464.html Eisai's news release EISAI ACCELERATES PROGRESS IN ONCOLOGY RESEARCH WITH NEW DATA AT ESMO CONGRESS 2024 is posted. 2024-09-05T08:30:00+09:00 /news/2024/news202463.html Eisai's news release 精东影业Announces Status Relating to Acquisition of Own Shares is posted. 2024-09-02T11:30:00+09:00 /news/2024/news202462.html Eisai's news release RELEASE OF INSOMNIA AWARENESS VIDEO FOR JAPAN鈥橲 AUTUMN SLEEP HEALTH WEEKS is posted. 2024-08-27T09:00:00+09:00